Tag: ONCY

Blue Horseshoe Stocks: Options, Bottom-Plays & More

GoPro, Inc. GPRO – Options

GPRO’s Q1 earnings beat on revenue and profits causing quite a surge in PPS. Yesterday the stock traded up from the $45-range to the $47-range, and this morning we’re observing a sizable gap-up, as GPRO has already changed hands for as much as 53.54 in the premarket.

In the midst of all this, we’ll be on the lookout for chances with GPRO Weekly Calls, most likely in the range from $49-51.50, with our strike price being dependent upon where the stock ultimately finds support off of this morning’s early highs.

It would fulfill a classic dip-and-rip scenario which by now, as our regular readers are well aware, is one of our favorite chart setups.

Windstream Holdings, Inc. WIN

We also want to point out the nice intraday move made by WIN following its inclusion in yesterday’s extended watchlist. The stock briefly touched a morning low of 10.71, before running 22% to a high of 13.05 on just under 4X its 3-month average volume.

The move came on the heels of upgrades for the stock from a number of Wall St. analysts, and over at one of our favorite data reference sites, BARCHART.COM, GPRO is currently receiving an 80% Short-Term “Buy” Rating.

LifeApps Digital Media, Inc. LFAP

LFAP is a potential subpenny bottom-play that is catching our attention this morning, and we wanted to pass it along to our readers. We’re always on the lookout for stocks trading at or near their 52-week lows, and not only does this one fit that bill, but the company also released some interesting news this morning.

At this price-point and in this situation, there’s always a chance for a nice rebound to provide quality opportunities for quick-strike trades.

SAN DIEGO, CA–(Marketwired – Apr 29, 2015) – LifeApps Digital Media Inc. (OTC PINK: LFAP) (“LifeApps”), an emerging growth company, and designer of m-health, fitness and sports applications (“apps”) has updated MDWorkout® its popular health app for Apple iPhone and iPad with integration with Apple HealthKit. >> FULL PR

Extended Watchlist:
MLER, ONCY, MCGC, GNW, ARNA

Blue Horseshoe Stocks: PMCB Update & More

PharmaCyte Biotech, Inc. PMCB

When we released a special report on PMCB back on Tuesday of last week, we commented on the promising nature of trials the company currently has underway relating to various treatments based on its Cell-in-a-Box® technology.

At the end of last week, PharmaCyte announced some promising research specifically pertaining to its diabetes treatment, with the claim that it can actually reverse Type-1 Diabetes in mice.The full paper can be found at http://www.nature.com/articles/mtm201511. Human trials are the next step to take, and needless to say, should the treatment prove effective using PMCB’s encapsulation technology (that we described in our initial report,) acquisition by a large pharmaceutical company could become a very real possibility.

That also seems to be the thinking on the Street, as PMCB has made some impressive strides on the chart over the past several sessions. From the low of .12 that we observed in this play on 04/08, it has made its way up as high as .22; a respectable 83% overall increase. That impressive high came during yesterday’s session in conjunction with a breach of the current 200DMA of .19.

PMCB will be one that we want to keep on continuous watch due to its potentially industry-disruptive diabetes treatment.

Pazoo, Inc. PZOO

PZOO has been a flipper’s dream since we re-initiated coverage on it just a couple of weeks ago. Yesterday’s low registered as .008 before the stock bounced back to .0097, a 21% intraday swing.

It was the same story on Wednesday; we saw PZOO dip to a low of .0074 before returning as high as .0103 (+39%) We’ve continually stated that we’d like to see the stock trading at or above the .008 range which, for the most part, it has continued to do.

CEO David Cunic appeared in an audio interview yesterday, and this morning we’re seeing another PR directing our attention to an 8-K filing which outlines a recent agreement, among other things, so our readers might want to check out those links.

In the meantime, we’ll be on the lookout for upcoming intraday gain opportunities from PZOO, such as those that it has delivered numerous time over the past several sessions.

Identiv, Inc. INVE

We also want to make a quick mention of INVE, which made a solid 14% move yesterday as it traded in a range from 11.12-12.67. It came on over ten times the 3-month average volume, so we’ll be observing this one as the week draws to a close, and possibly into next week.

Extended Watchlist:
RXII, ONCY, ZBB, UNXL

Blue Horseshoe Stocks: Big News for KRFT & More

Kraft (KRFT) to Merge With Heinz
–
In a move that will effectively create the third-biggest food company on the North American continent, it has been announced that Kraft Foods Group Inc. (KRFT) and H.J. Heinz Co. will merge. 3G Capital and Berkshire Hathaway, which bought Heinz for $23B and took it private back in 2013, will be orchestrating the deal.

As a result of this development, KRFT is gapping up monstrously in the premarket to the tune of more than 30% Generally when we see a stock soar on news like this, our first instinct is to continually scan for a dip-and-rip scenario once the session commences. When the rip does occur, we’re going to be looking to April $75-85 Calls for intraday options trading possibilities.

Kraft Foods, H.J. Heinz to Merge (Wed 8:18AM EDT)

Social Media Sector on Watch

Despite uncertainly over whether interest rates will be raised this year causing a general downturn in the markets, social media stocks appeared to be an exception yesterday.

We’re always looking for trends to exploit for options trading, and should Facebook, Inc. FB, Twitter, Inc. TWTR, and LinkedIn Corp. LNKD continue their hot hand this week, we could see some nice action in the following contracts:

FB Weekly $84-86 Calls
TWTR Weekly $50-52 Calls
LNKD Weekly $260-265 Calls

Vascular Biogenics, Inc. VBLT

VBLT is another gapper this morning that has surged in the premarket following the company Q4 earnings release. The stock briefly spiked to its 50DMA of 8.65 in early trading, and appears as if it will open in the 6.50’s.

We will look to see VBLT re-break the $7-mark once the session kicks off, as there is a large gap on the chart as we point out below, the filling of which would make for some highly notable gains. It’s definitely a stock we want to keep on our radar as we cruise through mid-week.

Extended Watchlist:
KFX, FXCM, ONCY, BLRX, MRNS, GRPN